Knowledge about TTP pathophysiology has considerably improved in recent decades: in 1982 Joel L Moake identified uncleaved von Willebrand Factor (VWF) multimers in patients with chronic relapsing TTP [2]. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.